Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             127 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A combination of KH1060, a vitamin D3 analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice Gysemans, C
 2001
 33 3 p. 2365-
1 p.
 artikel
2 Acute cardiac ongoing rejection: comparison between different strategies Forni, A
 2001
 33 3 p. 2395-2397
3 p.
 artikel
3 Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunities Feldmann, M
 2001
 33 3 p. 2085-2086
2 p.
 artikel
4 Antibody formation and its impact on long-term graft outcome Rose, M.L
 2001
 33 3 p. 2411-2413
3 p.
 artikel
5 Anti-CD4-induced long-term acceptance of rat liver allografts in a high-responder model is not based on pure immunosuppression Kohlhaw, K
 2001
 33 3 p. 2173-2175
3 p.
 artikel
6 Apoptosis after in vitro allostimulation of umbilical cord blood Chargui, J
 2001
 33 3 p. 2132-2133
2 p.
 artikel
7 Apoptosis: friend or foe? Fellström, B
 2001
 33 3 p. 2414-2416
3 p.
 artikel
8 A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity Marchal-Bras-Goncalves, R
 2001
 33 3 p. 2355-2359
5 p.
 artikel
9 Aspergillus infection in immunocompromised patients Koselj-Kajtna, M
 2001
 33 3 p. 2176-2178
3 p.
 artikel
10 Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays Barten, M.J
 2001
 33 3 p. 2119-2120
2 p.
 artikel
11 ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications van Gelder, T
 2001
 33 3 p. 2420-2421
2 p.
 artikel
12 Author index 2001
 33 3 p. 2433-2435
3 p.
 artikel
13 Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe Citterio, F
 2001
 33 3 p. 2134-2135
2 p.
 artikel
14 Basiliximab in the therapy of acute rejection after organ transplantation Chariat, M.N
 2001
 33 3 p. 2380-
1 p.
 artikel
15 Bone marrow transplantation across major genetic barriers: the role of megadose stem cells and nonalloreactive donor anti-third party CTLS Bachar-Lustig, E
 2001
 33 3 p. 2099-2100
2 p.
 artikel
16 Can recombinant hepatocyte growth factor suppress acute renal rejection? Yoshimura, R
 2001
 33 3 p. 2322-2323
2 p.
 artikel
17 CD4+ T-cell dynamics in primary cytomegalovirus infection Rentenaar, R.J
 2001
 33 3 p. 2313-2314
2 p.
 artikel
18 Cell cycle control and immunosuppression in organ transplantation Khanna, A
 2001
 33 3 p. 2101-2106
6 p.
 artikel
19 Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line Riteau, B
 2001
 33 3 p. 2360-2364
5 p.
 artikel
20 8-Chloro-cAMP modulates apoptosis of thymocytes and thymocyte hybridoma Colic, M
 2001
 33 3 p. 2347-2349
3 p.
 artikel
21 Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil Jain, S
 2001
 33 3 p. 2165-2166
2 p.
 artikel
22 Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution McGrath, J.S
 2001
 33 3 p. 2193-2195
3 p.
 artikel
23 Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563 Langrehr, J.M
 2001
 33 3 p. 2290-2291
2 p.
 artikel
24 C1-inhibitor protects human endothelial cell metabolic activity from prolonged cold storage Di Stefano, R
 2001
 33 3 p. 2269-2270
2 p.
 artikel
25 Coexpression of platelet-derived growth factors AA and BB and their receptors during monocytic differentiation Savikko, J
 2001
 33 3 p. 2307-2308
2 p.
 artikel
26 Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation Bilbao, I
 2001
 33 3 p. 2124-2126
3 p.
 artikel
27 Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy Jonas, S
 2001
 33 3 p. 2232-2233
2 p.
 artikel
28 Cyclosporine A downregulates intragraft platelet-derived growth factor-α mRNA expression after clinical heart transplantation de Groot-Kruseman, H.A
 2001
 33 3 p. 2241-2243
3 p.
 artikel
29 Cyclosporine A metabolite AM19 as a potential biomarker in urine for CSA nephropathy Kempkes-Koch, M
 2001
 33 3 p. 2167-2169
3 p.
 artikel
30 Cytokine producing function of type II T-helpers in transplanted kidney patients Drannik, G.N
 2001
 33 3 p. 2352-2354
3 p.
 artikel
31 Development of a novel drug for transplantation: current results and future perspectives Schorlemmer, H.U
 2001
 33 3 p. 2425-2428
4 p.
 artikel
32 1,25-dihydroxyvitamin D3 dose-dependently inhibits LPS-induced cytokines production in PBMC modulating intracellular calcium Giovannini, L
 2001
 33 3 p. 2366-2368
3 p.
 artikel
33 Dilitiazem reduces nitric oxide production by human immune cells D’Ambrosio, A
 2001
 33 3 p. 2139-2141
3 p.
 artikel
34 Echographic valuation of risk factors for cardiovascular disease in patients with renal transplantation Mazzarella, V
 2001
 33 3 p. 2188-2190
3 p.
 artikel
35 Effect of tacrolimus on the gene expression of renin and endothelin in the rat kidney Nakatani, T
 2001
 33 3 p. 2296-2297
2 p.
 artikel
36 Efficacy and safety of treatment with low-dose Fluvastatin in hypercholesterolemic renal transplant recipients Akiyama, T
 2001
 33 3 p. 2115-2118
4 p.
 artikel
37 Efficacy of malononitrilamide 715 as immunosuppressant, alone or in combination with cyclosporin, in allogeneic foetal rat pancreatic transplantation Muller, C.J.F
 2001
 33 3 p. 2229-2231
3 p.
 artikel
38 Erratum 2001
 33 3 p. 2431-
1 p.
 artikel
39 Evaluation of the immunomodulatory mechanisms of photochemotherapy in transplantation Legitimo, A
 2001
 33 3 p. 2266-2268
3 p.
 artikel
40 Evaluation of various immunosuppressive regimes in second renal transplants Toronyi, E
 2001
 33 3 p. 2315-2316
2 p.
 artikel
41 FK 506–mediated T-cell apoptosis induction Migita, K
 2001
 33 3 p. 2292-2293
2 p.
 artikel
42 FK 506 protects brain tissue in animal models of stroke McCarter, J.F
 2001
 33 3 p. 2390-2392
3 p.
 artikel
43 FTY-720 is efficacious in monkey kidney transplantation Quesniaux, V
 2001
 33 3 p. 2374-2375
2 p.
 artikel
44 Gene usage for naturally occurring antibodies Nydegger, U.E
 2001
 33 3 p. 2339-2340
2 p.
 artikel
45 Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts Moreau, P
 2001
 33 3 p. 2277-2280
4 p.
 artikel
46 Graft-versus-host disease-like features in mycophenolate mofetil-related colitis Papadimitriou, J.C
 2001
 33 3 p. 2237-2238
2 p.
 artikel
47 β-herpesvirus activation after kidney transplantation with mycophenolate mofetil–based maintenance immunosuppression Folkmane, I
 2001
 33 3 p. 2384-2385
2 p.
 artikel
48 High doses of cyclophosphamide in the treatment of severe systemic lupus erythematosus Glisic, B
 2001
 33 3 p. 2300-2301
2 p.
 artikel
49 High QT dispersion in tacrolimus-treated kidney transplant recipients Gerhardt, U
 2001
 33 3 p. 2148-2150
3 p.
 artikel
50 IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies Baan, C.C
 2001
 33 3 p. 2244-2246
3 p.
 artikel
51 Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis Kozák, T
 2001
 33 3 p. 2179-2181
3 p.
 artikel
52 Immunocompetence assay for net effect of combined immunosuppression Nagashima, N
 2001
 33 3 p. 2350-2351
2 p.
 artikel
53 Immunomodulatory properties of a 1,25(OH)2 vitamin D3 analog combined with IFNβ in an animal model of syngeneic islet transplantation van Etten, E
 2001
 33 3 p. 2319-
1 p.
 artikel
54 Immunosuppressants-ligands as neuroprotectants Kelly, J.S
 2001
 33 3 p. 2217-2219
3 p.
 artikel
55 Immunosuppression in ABO-incompatible transplantation Mohacsi, P
 2001
 33 3 p. 2223-2224
2 p.
 artikel
56 Immunosuppression in ANCA-associated vasculitis van der Woude, F.J
 2001
 33 3 p. 2225-2226
2 p.
 artikel
57 Immunosuppression in composite tissue allografts Petruzzo, P
 2001
 33 3 p. 2398-2399
2 p.
 artikel
58 Immunosuppressive therapy with cyclophosphamide pulse doses in Wegener’s granulomatosis Mitrovic, D
 2001
 33 3 p. 2378-2379
2 p.
 artikel
59 Induction of immunologic tolerance to tetanus toxoid by anti-human CD4 in HLA-DR3+/human CD4+/murine CD4− multiple transgenic mice Laub, R
 2001
 33 3 p. 2182-2183
2 p.
 artikel
60 Induction of xenotransplantation tolerance: a privileged role for the malononitrilamides Waer, M
 2001
 33 3 p. 2429-2430
2 p.
 artikel
61 Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients Varghese, Z
 2001
 33 3 p. 2251-2253
3 p.
 artikel
62 Inhibition of costimulatory pathways for T-cell activation by 1,25-dihydroxyvitamin D3 Penna, G
 2001
 33 3 p. 2083-2084
2 p.
 artikel
63 Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation Papageorgiou, C
 2001
 33 3 p. 2263-2265
3 p.
 artikel
64 Inhibition of TGF-β and VEGF expression in human endothelium cell lines with antisense-oligonucleotides: potential tools for gene therapy of chronic renal transplant rejection Hallscheidt, P
 2001
 33 3 p. 2157-2159
3 p.
 artikel
65 In memoriam 2001
 33 3 p. 2073-2074
2 p.
 artikel
66 Interaction of immunophilin-binding immunosuppressives with the glucocorticoid receptor signaling pathway: implications for transplantation Brogan, I.J.
 2001
 33 3 p. 2417-2419
3 p.
 artikel
67 Intravenous immunoglobulins in the therapy of severe bacterial infections, immunodeficiencies, and autoimmune diseases Popovic, M
 2001
 33 3 p. 2376-2377
2 p.
 artikel
68 Introduction Paul, L.C
 2001
 33 3 p. 2407-
1 p.
 artikel
69 In vivo inhibition of TNFα-induced vascular permeability by resveratrol Fulgenzi, A
 2001
 33 3 p. 2341-2343
3 p.
 artikel
70 Involvement of interleukin-2 and growth factors in chronic kidney allograft rejection in rats Hamar, P
 2001
 33 3 p. 2160-2162
3 p.
 artikel
71 Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice Gysemans, C
 2001
 33 3 p. 2094-2095
2 p.
 artikel
72 Leflunomide induces apoptosis of thymocytes and T-cell hybridoma: differences in sensitivity and signaling pathways Colic, M
 2001
 33 3 p. 2344-2346
3 p.
 artikel
73 Long-term effects of ATG therapy on lymphocyte subsets Martins, L
 2001
 33 3 p. 2186-2187
2 p.
 artikel
74 Long-term tacrolimus: a promising therapeutic approach for Crohn’s disease Ierardi, E
 2001
 33 3 p. 2107-2109
3 p.
 artikel
75 Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation Gerbase, M.W
 2001
 33 3 p. 2146-2147
2 p.
 artikel
76 Low rejection rate with high-dose ATG bolus therapy in simultaneous pancreas and kidney transplantation Saudek, F
 2001
 33 3 p. 2304-2306
3 p.
 artikel
77 Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization Nakache, R
 2001
 33 3 p. 2294-2295
2 p.
 artikel
78 Modulation of human peripheral blood mononuclear cell activation by the combination of leflunomide and pentoxifylline Stojic Vukanic, Z
 2001
 33 3 p. 2137-2138
2 p.
 artikel
79 Monitoring of ATG therapy by flow cytometry: comparison of one single-platform and two different dual-platform methods Reckzeh, B
 2001
 33 3 p. 2234-2236
3 p.
 artikel
80 Monoclonal anti-CD52 antibodies: a potential mode of therapy for parvovirus B19 hepatitis Granot, E
 2001
 33 3 p. 2151-2153
3 p.
 artikel
81 Mycofenolate mofetil–cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses Remport, A
 2001
 33 3 p. 2302-2303
2 p.
 artikel
82 Mycophenolate mofetil interferes with interferon γ production in T-cell activation models Izeradjene, K
 2001
 33 3 p. 2110-2111
2 p.
 artikel
83 Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience Basara, N
 2001
 33 3 p. 2121-2123
3 p.
 artikel
84 Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model Klupp, J
 2001
 33 3 p. 2170-2171
2 p.
 artikel
85 Neointima suppression in rat carotid allografts by FTY720 combined with a small fixed cyclosporine dose is related to a diminution of the peripheral lymphocyte count Nikolova, Z
 2001
 33 3 p. 2184-2185
2 p.
 artikel
86 Neonatal induction and maintenance of tolerance to Th2-induced immune manifestations in rats Field, A.C
 2001
 33 3 p. 2275-2276
2 p.
 artikel
87 New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus Klupp, J
 2001
 33 3 p. 2172-
1 p.
 artikel
88 New immunosuppressants in BMT/GVHD Basara, N
 2001
 33 3 p. 2220-2222
3 p.
 artikel
89 New immunosuppressives and clinical studies: an embarrassment of riches or more toxicity management? Guttmann, R.D
 2001
 33 3 p. 2079-2080
2 p.
 artikel
90 New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics Barten, M.J
 2001
 33 3 p. 2254-2255
2 p.
 artikel
91 New targets for the prevention of transplant vascular disease Häyry, P
 2001
 33 3 p. 2332-2333
2 p.
 artikel
92 OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation Meijer, R.T
 2001
 33 3 p. 2196-2197
2 p.
 artikel
93 Orthotopic aortic transplantation in rodents by the sleeve technique: a model system for the study of graft vascular disease Calise, D
 2001
 33 3 p. 2369-2370
2 p.
 artikel
94 Overview of clinical trials with new agents Charpentier, B
 2001
 33 3 p. 2201-2203
3 p.
 artikel
95 Overview of side effects of immunosuppressive therapy Paul, L.C
 2001
 33 3 p. 2089-2091
3 p.
 artikel
96 Pharmacokinetics of tacrolimus during the early phase after heart transplantation Molinaro, M
 2001
 33 3 p. 2386-2389
4 p.
 artikel
97 Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients Braun, F
 2001
 33 3 p. 2127-2128
2 p.
 artikel
98 Phase III trial of Rapamune versus placebo in primary renal allograft recipients Ponticelli, C
 2001
 33 3 p. 2271-2272
2 p.
 artikel
99 Procalcitonin: a new marker for diagnosis of acute rejection and nonviral infection of heart and lung transplant patients Hammer, C
 2001
 33 3 p. 2204-2206
3 p.
 artikel
100 Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood Amada, N
 2001
 33 3 p. 2256-2257
2 p.
 artikel
101 Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial Langrehr, J.M
 2001
 33 3 p. 2330-2331
2 p.
 artikel
102 RAD reduces compensatory renal graft hypertrophy in a rat model of chronic rejection Viklický, O
 2001
 33 3 p. 2320-2321
2 p.
 artikel
103 Regulatory tolerance-mediating T cells in transplantation tolerance Sawitzki, B
 2001
 33 3 p. 2092-2093
2 p.
 artikel
104 Side effects of interferon-α in treating hepatitis C virus infection Fontaine, H
 2001
 33 3 p. 2327-2329
3 p.
 artikel
105 Sirolimus and erythromycin interaction: two cases Claesson, K
 2001
 33 3 p. 2136-
1 p.
 artikel
106 Structural vessel wall properties in kidney transplant recipients depend on hyperparathyroidism Suwelack, B
 2001
 33 3 p. 2310-2312
3 p.
 artikel
107 Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease Fellermann, K
 2001
 33 3 p. 2247-2248
2 p.
 artikel
108 Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation Salizzoni, M
 2001
 33 3 p. 2258-2262
5 p.
 artikel
109 Tailoring immunosuppressive therapy based on donor and recipient risk factors First, M.R
 2001
 33 3 p. 2207-2211
5 p.
 artikel
110 T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy van Besouw, N.M
 2001
 33 3 p. 2239-2240
2 p.
 artikel
111 Temporary donor-derived B-lymphocyte microchimerism leading to hemolysis in minor AB0-incompatible renal transplantation Borka, P
 2001
 33 3 p. 2287-2289
3 p.
 artikel
112 The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection McGrath, J.S
 2001
 33 3 p. 2191-2192
2 p.
 artikel
113 The effect of Neoral on plasma cholesterol concentration in renal transplant recipients Konstadinidou, I
 2001
 33 3 p. 2393-2394
2 p.
 artikel
114 The immunosuppressant LF-150195 inhibits the progression of established collagen-induced arthritis by blockage of anticollagen IgG2a production Ducoroy, P
 2001
 33 3 p. 2281-2283
3 p.
 artikel
115 The immunosuppressant LF 15-0195 prevents collagen-induced arthritis with IL-10 down-regulation Ducoroy, P
 2001
 33 3 p. 2142-2145
4 p.
 artikel
116 The monoclonal anti-CD4 antibody RIB5/2 induces donor-specific tolerance in the high-responder liver transplant model in the rat Kohlhaw, K
 2001
 33 3 p. 2371-2373
3 p.
 artikel
117 The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation Hesse, C.J
 2001
 33 3 p. 2163-2164
2 p.
 artikel
118 Tolerability of mycophenolate mofetil in organ transplant recipients Schweizer, R.T
 2001
 33 3 p. 2309-
1 p.
 artikel
119 Tolerance induction by the graft itself Tullius , S.G.
 2001
 33 3 p. 2317-2318
2 p.
 artikel
120 Topical immunomodulatory agents and their targets in inflammatory skin diseases Wollenberg, A
 2001
 33 3 p. 2212-2216
5 p.
 artikel
121 Total serum homocysteine does not influence carotid intimal media thickness Suwelack, B
 2001
 33 3 p. 2381-2383
3 p.
 artikel
122 Transforming growth factor-beta: association with arteriosclerosis and left ventricular dysfunction after heart transplantation Aziz, T.M
 2001
 33 3 p. 2334-2336
3 p.
 artikel
123 Transplantation of cultured allogeneic hepatocytes without immunosuppression Fotiadis, C
 2001
 33 3 p. 2400-2403
4 p.
 artikel
124 Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation Grasser, B
 2001
 33 3 p. 2154-2156
3 p.
 artikel
125 Urinary retinol binding protein is a good marker of progressive cyclosporine nephrotoxicity after heart transplant Camara, N.O.S
 2001
 33 3 p. 2129-2131
3 p.
 artikel
126 Use of an isolated pancreatic graft (ex vivo) of swine as model for drug studies Papalois, A
 2001
 33 3 p. 2298-2299
2 p.
 artikel
127 Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients Lácha, J
 2001
 33 3 p. 2273-2274
2 p.
 artikel
                             127 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland